HercBridge ELISA     For Herceptin Biosimilar Comparison

Complete kit for the systematic 3-D conformational comparability analysis of 

Herceptin biosimilar molecule to Trastuzumab (Herceptin trade name)

Trastuzumab is a humanized monoclonal antibody is manufactured by Genentech and targets the HER2/neu receptor. Trastuzumab is approved for use in treating certain breast cancers and is being tested for other cancers that overexpress HER2/neu.

This kit will allow for conformational comparison between Herceptin Biosimilars and authentic Trastuzumab.

☞   Click here for detailed product instruction

☞   Click here for HercBridge MSDS